| |
PRZOOM - /newswire/ -
London, United Kingdom, 2008/03/18 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that the global market for the treatment of alcohol dependence will reach $304m by 2016.
|
| |
|
| |
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
| |
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that the global market for the treatment of alcohol dependence will grow at a compound annual growth rate of 13.5% from 2006 to reach $304m by 2016
The report, "Pipeline Insight - Substance Dependence - Part II (Alcohol)" finds that the main factors influencing the market will be the continued uptake of existing brands and the launch of two opioid antagonists. It reports that opioid eantagonists are the most prevalent drug class in late-stage development and include two reformulations of naltrexone.
Analysts state that the current alcohol dependence pipeline is weak and lacking in innovation, leaving market opportunity for new therapies. Additionally, they say that the efficacy of currently marketed pharmaceutical products is limited, displaying poor medication compliance rate in alcohol-dependent patients. This leads them to predict that pipeline drugs that possess the potential to improve patient compliance can expect to receive a strong uptake.
Authors of the report say that the alcohol dependence market requires a shift in public perception. They say alcohol dependence should no longer be seen as a behavioral disorder, but as a treatable medical condition. They also benchmark key late-stage anti- alcohol dependence compounds against the current market leader.
The study assesses the seven major markets and contains total sales forecasts of key late-stage pipeline drugs. It also examines their clinical and commercial potential. It forecasts key late-stage pipeline drugs revenues to 2016
"Pipeline Insight - Substance Dependence - Part II (Alcohol)" is available from Report Buyer. For more information, see website.
Report Buyer product ID: DAT09505
About Report Buyer
Report Buyer is a UK-based independent online store supplying business information. The website now carries over 44,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.
|
| |
 |
| |
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
| |
Agency / Source: Report Buyer Ltd
|
| |
 |
| |
Availability: All Regions (Including Int'l)
|
| |
Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker
|
| |
Distribution / Indexing: [+]
|
| |
 |
| |
# # #
|
| |
|
| |
 |
| |
Your Banner Ad showing on ALL Pharma / BioTech / Nutrition articles, CATCH Visitors via Your Competitors Announcements!
 Company website links NOT available to basic submissions |
|
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source. |
| |
 |
| |
For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
| |
Contact: Urmila Doraswami
+44 (0) 20 7060 7474 press[.]reportbuyer.com
|